Predictors of unfavourable prognosis in chronic Chagas' disease.

Item

http://www.wikidata.org/entity/Q43871653

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Predictors of unfavourable prognosis in chronic Chagas' disease.

@en

Predictors of unfavourable prognosis in chronic Chagas' disease.

@nl

type

Item

label

Predictors of unfavourable prognosis in chronic Chagas' disease.

@en

Predictors of unfavourable prognosis in chronic Chagas' disease.

@nl

prefLabel

Predictors of unfavourable prognosis in chronic Chagas' disease.

@en

Predictors of unfavourable prognosis in chronic Chagas' disease.

@nl

P1476

Predictors of unfavourable prognosis in chronic Chagas' disease.

@en

P2093

Bestetti RB

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography?

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.

A cost-benefit analysis of Chagas disease control.

Association of increased QT dispersion with coronary atherosclerosis in patients with aortic stenosis.

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

A rationale approach for mortality risk stratification in Chagas' heart disease.

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.

P304

476-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-3156.2001.00726.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11917475

http://www.w3.org/2001/XMLSchema#string

P698

11422962

http://www.w3.org/2001/XMLSchema#string

P921

Chagas disease